-
Something wrong with this record ?
Superoxide dismutase mimetic tempol inhibits hypoxic pulmonary vasoconstriction in rats independently of nitric oxide production
D Hodyc, M Snorek, T Brtnicky, J Herget
Language English Country Great Britain
NLK
Free Medical Journals
from 1999 to 1 year ago
Medline Complete (EBSCOhost)
from 2004-01-01
Wiley Online Library (archiv)
from 1999-01-01 to 2012-12-31
Wiley Free Content
from 1997 to 1 year ago
Wiley-Blackwell Open Access Titles
from 1997
- MeSH
- Antioxidants pharmacology MeSH
- Cyclic N-Oxides pharmacology MeSH
- Financing, Organized MeSH
- Hypoxia drug therapy metabolism MeSH
- Enzyme Inhibitors pharmacology MeSH
- Rats MeSH
- NG-Nitroarginine Methyl Ester pharmacology MeSH
- Nitric Oxide metabolism MeSH
- Pulmonary Circulation physiology drug effects MeSH
- Reactive Oxygen Species metabolism MeSH
- Spin Labels MeSH
- Superoxide Dismutase metabolism MeSH
- Vasoconstriction physiology drug effects MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
Hypoxic pulmonary vasoconstriction (HPV), an important physiological mechanism, is regulated by changes in the production of and interactions among reactive oxygen species (ROS). There is controversy, however, over whether HPV is mediated by an increase or a decrease in ROS production. Also, the role of NO in HPV remains unclear. The aim of this study was to investigate whether the inhibition of HPV by the antioxidant tempol was dependent on the concentration of NO, and how its effect was influenced by increased basal pulmonary vascular tone. In isolated rat lungs, we measured vasoconstrictor responses to acute ventilatory hypoxia before and after administration of tempol during perfusion with or without L-NAME. We found that tempol abolished HPV independently of NO production. When we increased basal vascular tone by K(+)-induced depolarization, we also found that tempol completely inhibited HPV. Our results indicate that inhibition of HPV by the superoxide dismutase mimetic tempol does not depend on either NO production or a decrease in basal vascular tone.
- 000
- 02848naa 2200445 a 4500
- 001
- bmc10010940
- 003
- CZ-PrNML
- 005
- 20121122124920.0
- 008
- 100507s2007 xxk e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Hodyc, Daniel, $d 1979- $7 xx0074202
- 245 10
- $a Superoxide dismutase mimetic tempol inhibits hypoxic pulmonary vasoconstriction in rats independently of nitric oxide production / $c D Hodyc, M Snorek, T Brtnicky, J Herget
- 314 __
- $a Department of Physiology, Charles University, Second Medical School, Prague, Czech Republic. daniel.hodyc@lfmotol.cuni.cz
- 520 9_
- $a Hypoxic pulmonary vasoconstriction (HPV), an important physiological mechanism, is regulated by changes in the production of and interactions among reactive oxygen species (ROS). There is controversy, however, over whether HPV is mediated by an increase or a decrease in ROS production. Also, the role of NO in HPV remains unclear. The aim of this study was to investigate whether the inhibition of HPV by the antioxidant tempol was dependent on the concentration of NO, and how its effect was influenced by increased basal pulmonary vascular tone. In isolated rat lungs, we measured vasoconstrictor responses to acute ventilatory hypoxia before and after administration of tempol during perfusion with or without L-NAME. We found that tempol abolished HPV independently of NO production. When we increased basal vascular tone by K(+)-induced depolarization, we also found that tempol completely inhibited HPV. Our results indicate that inhibition of HPV by the superoxide dismutase mimetic tempol does not depend on either NO production or a decrease in basal vascular tone.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a hypoxie $x farmakoterapie $x metabolismus $7 D000860
- 650 _2
- $a antioxidancia $x farmakologie $7 D000975
- 650 _2
- $a cyklické N-oxidy $x farmakologie $7 D003497
- 650 _2
- $a inhibitory enzymů $x farmakologie $7 D004791
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a NG-nitroargininmethylester $x farmakologie $7 D019331
- 650 _2
- $a oxid dusnatý $x metabolismus $7 D009569
- 650 _2
- $a plicní oběh $x fyziologie $x účinky léků $7 D011652
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a reaktivní formy kyslíku $x metabolismus $7 D017382
- 650 _2
- $a spinové značení $7 D013113
- 650 _2
- $a superoxiddismutasa $x metabolismus $7 D013482
- 650 _2
- $a vazokonstrikce $x fyziologie $x účinky léků $7 D014661
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Šnorek, Michal. $7 xx0241468
- 700 1_
- $a Brtnický, Tomáš. $7 xx0194016
- 700 1_
- $a Herget, Jan, $d 1945-2019 $7 nlk19990073223
- 773 0_
- $t Experimental Physiology $w MED00009720 $g Roč. 92, č. 5 (2007), s. 945-951 $x 0958-0670
- 910 __
- $a ABA008 $b x $y 8
- 990 __
- $a 20100525161900 $b ABA008
- 991 __
- $a 20121122124942 $b ABA008
- 999 __
- $a ok $b bmc $g 724797 $s 587944
- BAS __
- $a 3
- BMC __
- $a 2007 $b 92 $c 5 $d 945-951 $i 0958-0670 $m Experimental physiology $n Exp Physiol $x MED00009720
- LZP __
- $a 2010-B2/dkme